Literature DB >> 12869398

Cigarette smoking and risk of prostate cancer in middle-aged men.

Lora A Plaskon1, David F Penson, Thomas L Vaughan, Janet L Stanford.   

Abstract

Cigarette smoking may increase the risk of prostate cancer by affecting circulating hormone levels or through exposure to carcinogens. Although there are plausible mechanisms that could explain an association between smoking and prostate cancer, previous studies are inconsistent. The goal of this population-based case-control study was to assess this association in middle-aged men. Cases (n = 753) were men ages 40-64 years diagnosed with prostate cancer from 1993 to 1996 identified using the Seattle-Puget Sound Cancer Registry. Age-matched controls without prostate cancer from the same region (n = 703) were identified using random digit dialing. Participants completed detailed in-person interviews. Logistic regression was used to compute adjusted odds ratios (ORs) and 95% confidence intervals (CIs) to assess the prostate cancer-cigarette smoking relationship. Current smokers had an increased risk (OR = 1.4, 95% CI 1.0-2.0) relative to nonsmokers. A dose-response relationship was noted between number of pack-years smoked and prostate cancer risk (trend P = 0.03). The OR = 1.6 (95% CI 1.1-2.2) for men with >40 pack-years of smoking, with a stronger association observed in men with more aggressive disease (OR = 2.0, 95% CI 1.3-3.1). Smoking cessation resulted in a decline in risk (trend P = 0.02). Smoking is associated with a moderately increased relative risk of prostate cancer. Furthermore, a dose-response relationship exists between number of pack-years smoked and cancer risk. Given that smoking cessation seems to reduce these risks, results from this study have public health ramifications and suggest that prostate cancer should be added to the list of tumors for which cigarette smoking is a risk factor.

Entities:  

Mesh:

Year:  2003        PMID: 12869398

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Significance of smoking status regarding outcomes after radical prostatectomy.

Authors:  Jong Jin Oh; Sung Kyu Hong; Chang Wook Jeong; Seok-Soo Byun; Sang Eun Lee
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

2.  Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.

Authors:  Amit M Algotar; Steven P Stratton; James Ranger-Moore; M Suzanne Stratton; C H Hsu; Frederick R Ahmann; Raymond B Nagle; Patricia A Thompson
Journal:  Am J Mens Health       Date:  2011-05

3.  Testosterone and prostate health: Have the paradigms truly shifted?

Authors:  Alvaro Morales; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2020-08       Impact factor: 1.862

4.  Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts
Journal:  J Health Care Poor Underserved       Date:  2011

Review 5.  Environmental factors in causing human cancers: emphasis on tumorigenesis.

Authors:  Umesh T Sankpal; Hima Pius; Moeez Khan; Mohammed I Shukoor; Pius Maliakal; Chris M Lee; Maen Abdelrahim; Sarah F Connelly; Riyaz Basha
Journal:  Tumour Biol       Date:  2012-05-22

6.  Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancer.

Authors:  Yu-Ning Wong; Elliot J Coups
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

7.  Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Authors:  Dante D Cáceres; Jeannette Iturrieta; Cristian Acevedo; Christian Huidobro; Nelson Varela; Luis Quiñones
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

8.  Cigarette smoking and prostate cancer in a prospective US cohort study.

Authors:  Joanne L Watters; Yikyung Park; Albert Hollenbeck; Arthur Schatzkin; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-25       Impact factor: 4.254

9.  An androgen-independent mechanism underlying the androgenic effects of 3-methylcholanthrene, a potent aryl hydrocarbon receptor agonist.

Authors:  Noriko Sanada; Yuka Gotoh-Kinoshita; Naoya Yamashita; Ryoichi Kizu
Journal:  Toxicol Res (Camb)       Date:  2020-05-14       Impact factor: 3.524

10.  Cytokine genetic polymorphisms and prostate cancer aggressiveness.

Authors:  Jovanny Zabaleta; L Joseph Su; Hui-Yi Lin; Rosa A Sierra; M Craig Hall; A Oliver Sartor; Peter E Clark; Jennifer J Hu; Augusto C Ochoa
Journal:  Carcinogenesis       Date:  2009-05-27       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.